Systemic mastocytosis with associated hematologic neoplasm (SM-AHN) presents unique diagnostic and treatment challenges. In this Medscape-certified activity, experts discuss the complex patient journey, from delayed diagnosis to individualized…
Avapritinib, branded as Ayvakit, became the first FDA-approved treatment for indolent systemic mastocytosis (ISM) in 2023, marking a major advancement for patients. ISM, driven by the KIT D816V…
Part 1 – Case Presentation Brian A. Jonas, MD, PhD, FACP, presents the case of patient “A.B.” to fellow faculty members Daniel A. Pollyea, MD, MS and Gabriel…
Part 2 – Case Discussion Brian A. Jonas, MD, PhD, FACP, presents the case of patient “A.B.” to fellow faculty members Daniel A. Pollyea, MD, MS and Gabriel…
Part 3 – Case Discussion & Wrap-up Brian A. Jonas, MD, PhD, FACP, presents the case of patient “A.B.” to fellow faculty members Daniel A. Pollyea, MD, MS…
